盐酸氯米帕明,CAS 登记号 17321-77-6,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于医药中间体及原料药。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 盐酸氯米帕明 的 CAS 号:17321-77-6,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
clomipramine hydrochloride · CAS 17321-77-6 · C19H24Cl2N2. UNII 2LXW0L6GWJ.
| CAS Registry Number | 17321-77-6 |
|---|---|
| PubChem CID | 68539 |
| Molecular formula | C19H24Cl2N2 |
| IUPAC name | 3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride |
| UNII (FDA) | 2LXW0L6GWJ |
| Molecular Weight | 351.3 |
|---|---|
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 4 |
| Exact Mass | 350.1316542 |
| Monoisotopic Mass | 350.1316542 |
| Topological Polar Surface Area | 6.5 |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 346 |
| Reported hazard statements | H302 (100%), H312 (65.6%), H315 (63.9%), H319 (63.9%), H332 (65.6%), H335 (62.3%), H361 (24.6%), H400 (26.2%) |
|---|
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
H312 (65.6%): Harmful in contact with skin [Warning Acute toxicity, dermal]
Clomipramine hydrochloride; 17321-77-6; Clomipramine HCL; 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride; 3-Chloroimipramine hydrochloride; Chloroimipramine monohydrochloride; DTXSID3042633; 2LXW0L6GWJ; NSC-759323; G 34586; G-34586; 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine monohydrochloride; 5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-, monohydrochloride; CHEBI:3755; DTXCID1022633; 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine monohydrochloride
CAS 17321-77-6; molecular formula C19H24Cl2N2; molecular weight — g/mol.
Clomipramine hydrochloride, 17321-77-6, Clomipramine HCL, 3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, 3-Chloroimipramine hydrochloride, Chloroimipramine monohydrochloride.
Hazard statements reported: H302, H312, H315, H319, H332.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.